SCHEMBL4149913

SCHEMBL4149913

O=C(CNC(=O)c1ccccc1)N[C@@H](CCCSCC(=O)C(F)(F)F)C(=O)NCc1csc(-c2ccccc2)n1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.43
ALDH1A1 P00352 3/20 0.42
ROCK2 O75116 2/20 0.42
GRK2 P25098 1/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 1/20 0.41
KDM4E B2RXH2 2/20 0.40
RHOC P08134 1/20 0.40
RHOA P61586 1/20 0.40
HPGD P15428 2/20 0.40
LMNA P02545 3/20 0.40
HTT P42858 1/20 0.40
MAPT P10636 2/20 0.39
TP53 P04637 1/20 0.39
GAA P10253 1/20 0.39
SHMT1 P34896 1/20 0.39
ROCK1 Q13464 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4174440 0.85 SHMT1 (0.41) ALDH1A1NPC1RAB9AKDM4EHPGD
SCHEMBL4159878 0.84 ROCK2 (0.45) SMN1; SMN2ALDH1A1ROCK2GRK2NPC1
SCHEMBL4166182 0.84 PADI4 (0.48) SMN1; SMN2ALDH1A1ROCK2GRK2NPC1
SCHEMBL4163977 0.83 MLYCD (0.46) SMN1; SMN2ALDH1A1NPC1RAB9AKDM4E
SCHEMBL4161122 0.79 NPC1 (0.46) SMN1; SMN2NPC1RAB9A
SCHEMBL4149916 0.79 SMN1; SMN2 (0.41) SMN1; SMN2ALDH1A1ROCK2GRK2NPC1
SCHEMBL4166894 0.79 KDM4E (0.43) ALDH1A1KDM4EHPGDLMNAHTT
SCHEMBL5130154 0.79 NPC1 (0.46) SMN1; SMN2ALDH1A1ROCK2GRK2NPC1
SCHEMBL4160443 0.78 KDM4E (0.39) ALDH1A1NPC1RAB9AKDM4EHPGD
SCHEMBL4169059 0.77 KDM4E (0.39) SMN1; SMN2ALDH1A1NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors JONES PHILIP 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC5, HDAC1, HDAC11 SMN1; SMN2 1280/4885ALDH1A1 320/4885ROCK2 2524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.